• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AUA
Click for more information
0.00% 5.0¢

AUDEARA LIMITED - Charts / Financials

Market Cap $7.261M  ! watchlist Created with Sketch. Add to my watchlist
Technology Consumer Electronics

Audeara Limited is a global hearing health company. The Company specializes in listening... Audeara Limited is a global hearing health company. The Company specializes in listening solutions for people with hearing challenges. Its principal activity is development of hearing health technology. Its headphones deliver personalized audio to users via Bluetooth headphones. Its headphones are categorized as an assistive listening device (ALD), which can be paired with its mobile application called the Audeara App. Its technology is compatible for use with cochlear implants and hearing aids. The Audeara App uses a personalized algorithm to calibrate the headphones for an individual’s hearing profile. This provides clear sound quality for video conferencing and telephone calls and using mainstream applications like watching television, listening to music, and gaming. Its products include A-01 Headphones, BT-01 Transceiver, A-02 Headphones and A-02 TV Bundle. It sells its products through distributors and resellers in Australia and North America, and via e-commerce channels.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 16.20pm 03/10/2024 (20 minute delay) ?
Day
Open 5.0¢   Day High 5.0¢   Day Low 5.0¢
Daily Volume 10039
Bids   Sellers
Number Price Volume   Number Price Volume
1 4.0¢ 14075   1 5.0¢ 22024

Directors & Senior Management

Mr. James D. Fielding Chief Executive Officer, Managing Director
Mr. Hsin Chieh Peng Executive Director
Mr. Stephen Buckley Company Secretary
Mr. David Trimboli Non-Executive Chairman of the Board

Data source: Refinitiv

(20min delay)
Last
5.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $7.261M
Open High Low Value Volume
5.0¢ 5.0¢ 5.0¢ $502 10.03K

Buyers (Bids)

No. Vol. Price($)
1 14075 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 22024 1
View Market Depth
Last trade - 13.12pm 03/10/2024 (20 minute delay) ?

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Firefly positioned for copper growth in Canada ahead of resource update Firefly Metals Ltd has reported drilling reports from its Green Bay copper-gold project in Newfoundland, ahead of a resource update
Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20% Chariot has unveiled its vision for its US-based Black Mountain – aiming to fast-track its path to production by establishing a "pilot mine."
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.